Partnering With Us

The company is currently seeking strategic alliances in these therapeutic areas with partners who wish to access our experience and insights, as well as access the following core competencies:

• Orphan pharmaceutical development
• Clinical development
• Pre-approval distribution of Orphan drugs through third-party contractors in accordance with governmental regulations
• Accelerated registration in the United States, Canada, Mexico, and South America
• Effective and efficient, targeted sales and distribution
• Secure and rapid delivery of products
• Single source distribution
• Pricing and reimbursement strategies to optimize product utilization
• Orphan product regulatory maintenance

Through creative strategic alliances, as well as unique relationships with the government, research institutions, physicians, scientists, and manufactures, Rare Disease Therapeutics, Inc., is able to provide options where there are no options—to provide therapies where there are no therapies.

To contact us regarding opportunities, please do so via our Contact form.